Advances in Pediatric Research
Open Access
ISSN: 2385-4529
+44 1223 790975
ISSN: 2385-4529
+44 1223 790975
CS Parque Loranca, C/ de la Alegría 2, 28942 Fuenlabrada, Madrid, Spain
Research Article
A multicenter, randomized, blinded, controlled clinical trial investigating the effect of a novel infant formula on the body composition of infants: INNOVA 2020 study protocol
Author(s): Francisco Javier Ruiz-Ojeda, Julio Plaza-Díaz, Javier Morales, Ana Isabel Cristina de la Torre, Antonio García-García, Carlos Nuñez de Prado, Cristóbal Coronel, Cyntia Crespo, Eduardo Ortega, Esther Martín-Pérez, Fernando Ferreira, Gema García-Ron, Ignacio Galicia, María Teresa Santos-García Cué, Marcos Maroto, Paola Ruiz, Raquel Martín, Susana Viver-Gómez and Ángel Gil*
Background: Breastmilk is the ideal food for infants and exclusive breastfeeding is recommended. In the clinical trial aimed to evaluate a new starting formula on weight gain of infants up to 6 and 12 months. The novel formula was compared with a standard formula and breastfeeding, the latter being used as the reference method.
Objectives: The main objective of this study was to evaluate the weight gain in children fed with a new starting infant formula INN for 12 months, with a low level of total protein, enriched in α-lactalbumin protein to get a proportion of whey proteins to caseins of 70/30, as well as enriched levels of Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) (about 2 times than STD infant formula), and supplemented with the postbiotic Bifidobacterium animalis subspecies lactis (BPL1™.. View More»
DOI:
10.35248/2385- 4529.22.9.041